Hubei Goto Biopharm Co Ltd
SZSE:300966
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hubei Goto Biopharm Co Ltd
Free Cash Flow
Hubei Goto Biopharm Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hubei Goto Biopharm Co Ltd
SZSE:300966
|
Free Cash Flow
-¥332.2m
|
CAGR 3-Years
-116%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Free Cash Flow
¥12.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Free Cash Flow
¥644.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Free Cash Flow
-¥147.1m
|
CAGR 3-Years
58%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Free Cash Flow
-¥1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Free Cash Flow
-¥306.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hubei Goto Biopharm Co Ltd
Glance View
Hubei Goto Biopharm Co., Ltd. engages in the research, development, production, and sale of steroidal drug raw materials. The company is headquartered in Xiangfan, Hubei and currently employs 481 full-time employees. The company went IPO on 2021-04-09. The firm's main products are starting materials and intermediates required for the production of steroid drugs. The starting materials refer to the products obtained from the conversion of plant sterols through biological fermentation technology. These products are important raw materials for downstream pharmaceutical intermediates and active pharmaceutical ingredient manufacturers and belong to the upstream products in the steroid drug industry chain. The firm's intermediate products mainly include sex hormone intermediates, progesterone intermediates, corticosteroid intermediates and other products.
See Also
What is Hubei Goto Biopharm Co Ltd's Free Cash Flow?
Free Cash Flow
-332.2m
CNY
Based on the financial report for Dec 31, 2024, Hubei Goto Biopharm Co Ltd's Free Cash Flow amounts to -332.2m CNY.
What is Hubei Goto Biopharm Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-68%
Over the last year, the Free Cash Flow growth was 3%. The average annual Free Cash Flow growth rates for Hubei Goto Biopharm Co Ltd have been -116% over the past three years , -68% over the past five years .
